Open AccessSignaling pathway of insulin-like growth factor-II as a target of molecular therapy for hepatoblastoma
Author(s) -
M. Tomizawa
Publication year - 2006
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v12.i40.6531
Subject(s) - hepatoblastoma , wortmannin , insulin like growth factor , cell growth , growth factor , ly294002 , phosphoinositide 3 kinase , pi3k/akt/mtor pathway , biology , signal transduction , microbiology and biotechnology , cancer research , chemistry , endocrinology , medicine , receptor , biochemistry
To address the possibility that insulin-like growth factor (IGF)-II is a growth factor and its signaling pathway so as to develop a molecular therapy for hepatoblastoma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom